Raphael A. Nemenoff

8.4k total citations
118 papers, 7.1k citations indexed

About

Raphael A. Nemenoff is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Raphael A. Nemenoff has authored 118 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Physiology. Recurrent topics in Raphael A. Nemenoff's work include Protein Kinase Regulation and GTPase Signaling (21 papers), Metabolism, Diabetes, and Cancer (15 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Raphael A. Nemenoff is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (21 papers), Metabolism, Diabetes, and Cancer (15 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Raphael A. Nemenoff collaborates with scholars based in United States, United Kingdom and Japan. Raphael A. Nemenoff's co-authors include Joseph Avruch, Perry J. Blackshear, J H Gronich, Joseph V. Bonventre, Vicki Van Putten, Lynn E. Heasley, Mary C.M. Weiser‐Evans, Gary L. Johnson, Mark Pierce and Mark W. Geraci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Raphael A. Nemenoff

118 papers receiving 6.9k citations

Peers

Raphael A. Nemenoff
Chris J. Vlahos United States
Jeffrey I. Kreisberg United States
Darren A.E. Cross United Kingdom
Yan Xu United States
Robert H. Weiss United States
Ru Wei United States
David B. Shackelford United States
Chris J. Vlahos United States
Raphael A. Nemenoff
Citations per year, relative to Raphael A. Nemenoff Raphael A. Nemenoff (= 1×) peers Chris J. Vlahos

Countries citing papers authored by Raphael A. Nemenoff

Since Specialization
Citations

This map shows the geographic impact of Raphael A. Nemenoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael A. Nemenoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael A. Nemenoff more than expected).

Fields of papers citing papers by Raphael A. Nemenoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael A. Nemenoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael A. Nemenoff. The network helps show where Raphael A. Nemenoff may publish in the future.

Co-authorship network of co-authors of Raphael A. Nemenoff

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael A. Nemenoff. A scholar is included among the top collaborators of Raphael A. Nemenoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael A. Nemenoff. Raphael A. Nemenoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Sizhao, Keith A. Strand, Marie F Mutryn, et al.. (2023). Smooth muscle–derived adventitial progenitor cells direct atherosclerotic plaque composition complexity in a Klf4-dependent manner. JCI Insight. 8(22). 5 indexed citations
2.
Kleczko, Emily K., Michael Berger, Seth B. Furgeson, et al.. (2023). Immune checkpoint activity regulates polycystic kidney disease progression. JCI Insight. 8(12). 9 indexed citations
4.
Kleczko, Emily K., Nidhi Dwivedi, Berenice Y. Gitomer, et al.. (2022). The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression. JCI Insight. 8(1). 13 indexed citations
5.
Thurman, Joshua M., Jennifer Laskowski, & Raphael A. Nemenoff. (2020). Complement and Cancer—A Dysfunctional Relationship?. SHILAP Revista de lepidopterología. 9(4). 61–61. 16 indexed citations
6.
Lu, Sizhao, Keith A. Strand, Marie F Mutryn, et al.. (2020). Smooth muscle–derived progenitor cell myofibroblast differentiation through KLF4 downregulation promotes arterial remodeling and fibrosis. JCI Insight. 5(23). 39 indexed citations
7.
Laskowski, Jennifer, Brandon Renner, Matthew C. Pickering, et al.. (2020). Complement factor H–deficient mice develop spontaneous hepatic tumors. Journal of Clinical Investigation. 130(8). 4039–4054. 49 indexed citations
8.
Thurman, Joshua M. & Raphael A. Nemenoff. (2016). Never make assumptions: the complicated role of complement in urinary tract infections. Kidney International. 90(3). 469–471. 5 indexed citations
9.
Montford, John R., Henrick Horita, Allison C. Ostriker, et al.. (2014). Activation of the Retinoid X Receptor Modulates Angiotensin II-Induced Smooth Muscle Gene Expression and Inflammation in Vascular Smooth Muscle Cells. Molecular Pharmacology. 86(5). 570–579. 10 indexed citations
10.
Andrés-Hernando, Ana, Christopher Altmann, Miguel A. Lanaspa, et al.. (2011). Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. American Journal of Physiology-Renal Physiology. 301(4). F907–F916. 62 indexed citations
11.
Furgeson, Seth B., Peter Simpson, In-Sun Park, et al.. (2010). Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovascular Research. 86(2). 274–282. 78 indexed citations
12.
Thurman, Joshua M., P Royer, Jian Zhou, et al.. (2007). C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion. The Journal of Immunology. 178(3). 1819–1828. 101 indexed citations
13.
Nemenoff, Raphael A.. (2007). Peroxisome Proliferator-Activated Receptor-γ in Lung Cancer: Defining Specific Versus “Off-Target― Effectors. Journal of Thoracic Oncology. 2(11). 989–992. 28 indexed citations
14.
Meyer, Amy M., Lori D. Dwyer‐Nield, Gregory J. Hurteau, et al.. (2006). Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2null mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(6). L1260–L1266. 11 indexed citations
15.
Ihida‐Stansbury, Kaori, David McKean, Sarah A. Gebb, et al.. (2004). Paired-Related Homeobox Gene Prx1 Is Required for Pulmonary Vascular Development. Circulation Research. 94(11). 1507–1514. 63 indexed citations
16.
Nana‐Sinkam, Patrick, Heiko Golpon, Robert L. Keith, et al.. (2004). Prostacyclin in Human Non-small Cell Lung Cancers. CHEST Journal. 125(5). 141S–141S. 13 indexed citations
17.
Walker, Heather, John M. Whitelock, Pamela J. Garl, et al.. (2003). Perlecan Up-Regulation of FRNK Suppresses Smooth Muscle Cell Proliferation via Inhibition of FAK Signaling. Molecular Biology of the Cell. 14(5). 1941–1952. 48 indexed citations
18.
Putten, Vicki Van, Stacy A. Blaine, Marilee J. Wick, et al.. (2001). Induction of Cytosolic Phospholipase A2 by Oncogenic Ras Is Mediated through the JNK and ERK Pathways in Rat Epithelial Cells. Journal of Biological Chemistry. 276(2). 1226–1232. 55 indexed citations
19.
Nemenoff, Raphael A.. (1998). Vasopressin signaling pathways in vascular smooth muscle. Frontiers in bioscience. 3(4). d194–207. 42 indexed citations
20.
Edelstein, Charles L., Hong Ling, Patricia E. Gengaro, et al.. (1997). Effect of glycine on prelethal and postlethal increases in calpain activity in rat renal proximal tubules. Kidney International. 52(5). 1271–1278. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026